Pancreatic Cancer Research

ResearcherPennsylvania State UniversityActive in the last 2 years

Manoj Kumar Pandey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2767-2929; OpenAlex author ID A5101680849. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer. Last author DOI 10.1016/j.seminoncol.2025.152411↗
  2. Targeting the complement system in pancreatic cancer drug resistance: a novel therapeutic approach. Co-author DOI 10.20517/cdr.2021.150↗
  3. Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-κB Signaling, and Synergizes wi… Co-author DOI 10.3390/ijms22094966↗
  4. Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer. Last author DOI 10.3390/ijms19123890↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kartick Chandra Pramanik · 3 shared papers, 2018–2025 · strength 0.59
  2. Daniel A. Guirguis · 1 shared paper, 2025 · strength 0.28
  3. Naushair Hussain · 1 shared paper, 2022 · strength 0.19
  4. Junxuan Lü · 1 shared paper, 2021 · strength 0.15
  5. Deepkamal N. Karelia · 1 shared paper, 2021 · strength 0.15
  6. Arun Kumar Sharma · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.